Year Founded
2008
Ownership
Private
Employees
~10001
Therapeutic Areas
NeurologyDermatology
Stage
Commercial
Modalities
Small moleculeOther

Promius Pharma General Information

Subsidiary of Dr. Reddy's focused on dermatology products. Sold its US rights for dermatology brands including SERNIVO, PROMISEB, and TRIANEX to Encore Dermatology in 2019.

Contact Information

Website
Primary Industry
[ "Biotech", "Pharma" ]
Corporate Office
Princeton, New Jersey
USA

Drug Pipeline

betamethasone dipropionate
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Promius Pharma's pipeline data

Book a demo

Key Partnerships

Encore Dermatology

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Promius Pharma Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Promius Pharma's complete valuation and funding history, request access »